GL1X · GenesisL1 explorer

MolNFT v1 · #36134 · protein

Dual binding mode of pyridinylimidazole to MAP kinase P38

2EWA · Mitogen-activated protein kinase 14: “Dual binding mode of pyridinylimidazole to MAP kinase P38”. X-ray diffraction, 1 ligand (SB2), 5 pockets (best druggability 0.73). MolNFT v1 #36134 on GenesisL1: 3D structure, binding sites and…

PDB
2EWA
Type
protein
Length
330 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 14
EC
2.7.1.37
UniProt
P47811
Ligands
SB2
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 14 (EC 2.7.1.37)protein33039% helix, 16% strandP47811

Ligands and binding sites

  • SB2 · 4-[5-(4-fluoro-phenyl)-2-(4-methanesulfinyl-phenyl)-3H-imidazol-4-yl]-pyridine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15840.730.8055SB2
2930.670.9120empty
31590.450.7529empty
41370.410.7527empty
5640.290.7316empty

Compared structures

  • 2EWA · Dual binding mode of pyridinylimidazole to MAP kinase p38 · the same entry in another collection · chain A against A, TM-score 1.00
  • P47811 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 14 (P47811) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.